Business Context and Reporting Period
Calidi Biotherapeutics, Inc. (CLDI) filed a Form 8-K on July 10, 2026, reporting the entry into a new lease agreement and the termination of an existing lease for its San Diego, California facilities. The company is an emerging growth company incorporated in Delaware.
Key Financial Metrics and Obligations
- Estimated Annual Savings: Approximately $1.1 million in rent and facility-related expenses.
- New Lease Term: 44 months, commencing October 1, 2026, and expiring May 31, 2030.
- Extension Option: One option to extend for an additional three years at fair market rental rates, subject to conditions.
- Security Requirement: An irrevocable letter of credit in the amount of $113,574.78 must be delivered within 10 calendar days of execution.
- Termination Fee: No early termination fee was paid to the prior landlord.
Material Changes Versus Prior Period
The company is consolidating or relocating its operations from the "Existing Premises" at 4475 Executive Drive to the "New Premises" at 5580 Morehouse Drive. The prior lease, originally scheduled to expire in February 2027, will terminate effective September 30, 2026. Both the prior and new landlords are affiliates. This transition is expected to reduce annual operating costs significantly.
Outlook, Risks, and Contingencies
- Transition Contingency: If substantial completion of the new premises is not achieved by September 30, 2026, the company may remain in the existing premises for up to 14 days following completion.
- Holdover Risk: Failure to timely vacate the existing premises will trigger holdover provisions under the prior lease.
- Extension Conditions: The lease extension option requires the company to not be in default and to occupy at least 50% of the new premises at the time of exercise.
- Liquidity Impact: The requirement to post a letter of credit represents a direct financial obligation and potential liquidity constraint.
Investor Verification Checklist
- Verify the actual move-in date and whether the September 30, 2026, termination deadline is met without triggering holdover fees.
- Confirm the execution of the $113,574.78 letter of credit and its impact on available cash or credit lines.
- Review the full text of the New Lease (Exhibit 10.1) for specific rental rates and operating expense definitions to validate the $1.1 million savings estimate.
- Monitor the company's cash burn rate to ensure it can sustain operations while transitioning facilities.